AUPH – aurinia pharmaceuticals inc - common shares (US:NASDAQ)
Stock Stats
News
Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
Aurinia to Participate in Jefferies London Healthcare Conference [Yahoo! Finance]
Aurinia to Participate in Jefferies London Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Aurinia Pharmaceuticals Inc (AUPH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
Form SC 13G/A Aurinia Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC
Form 4 Aurinia Pharmaceuticals For: Nov 08 Filed by: Bailey Jeffrey Allen
Form 4 Aurinia Pharmaceuticals For: Nov 08 Filed by: Smith Karen L.
Form 3 Aurinia Pharmaceuticals For: Nov 07 Filed by: Keenan Greg
Form 3 Aurinia Pharmaceuticals For: Nov 07 Filed by: Johnson Craig A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.